Edwards Lifesciences Corporation (EW)

SEC filing

Edwards Lifesciences Corporation

EW · CIK 1099800

4 · Oct 8, 2026 · CVP, TAVR Lippis Daniel J. sold 619 shares at $85.65/share ($53,017); exercised options for 1,238 shares

CVP, TAVR Lippis Daniel J. sold 619 shares at $85.65/share ($53,017); exercised options for 1,238 shares

xslF345X06/doc4.xml

xslF345X06/doc4.xmlSEC.gov

Graphics and non-inline formats (not embedded below).